translate
Research News
IPF Research
Life with PF
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
PFF Educational Resources
PFF Educational Videos
Our Role
Who We Are
News & Media
Community Programs
Leadership
Financials
Contact Us
Career Opportunities
Get Involved
Attend an Event
Advocacy
Broadway Belts for PFF
Fundraise for Team PFF
PFF Walk
PF Awareness Month
Share Your Story
Shop at the PFF Store
Ways to Give
Donate Now
Day of Giving
Honor a Loved One
Support PFF at Work
Donate Stocks and Bonds
Planned Giving
Medical Community
PFF Research Funds
Partnership Grants
Sponsorship Opportunities
Leanne Storch Support Group Fund
PFF Summit
PFF Care Center Network
PFF Patient Registry
Connect With Patients
CME/CE Library
Health Provider Resources
Contact Us
join our
e
newsletter
|
translate
Join Our Monthly eNewsletter
Subscribe to receive the most current news and updates from the Pulmonary Fibrosis Foundation.
Life with PF
Education & Support
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Pipeline
Research News
IPF Research
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
Local and International
Online Support Communities
Support Group Leader Network
PFF Educational Resources
Webinars
Ask A Doc March 2015
Patient Education Materials
PF Community Resources
Life with Pulmonary Fibrosis
Advocacy in Action Webinar Series
PFF Educational Videos
Our Role
Information & Programs
Who We Are
News & Media
News
Breathe Bulletin
Archive
Media Resources
PFF in the Media
Community Programs
PFF Care Center Network
PFF Patient Registry
PF Awareness Month
PFF Summit
PFF Patient Communication Center
PFF Oxygen Information Line
PFF Support Group Leader Network
PFF Ambassador Program
PFF Educational Videos
Leadership
Board of Directors
Stephen A. Wald
Stephen A. Wald
Joseph Borus
Stephen A. Wald
Medical Advisory Board
Research Review Committee
Medical and Scientific Advisory Committee
Financials
Contact Us
Career Opportunities
Get Involved
Events & Awareness
Attend an Event
Advocacy
Broadway Belts for PFF
Fundraise for Team PFF
PFF Walk
PF Awareness Month
Share Your Story
Shop at the PFF Store
Ways to Give
Donations & Tributes
Donate Now
Day of Giving
Honor a Loved One
Create or Donate to an Online Tribute/Memorial
Set Up Memorial Contributions
Celebrate Lifetime Events
Support PFF at Work
Donate Stocks and Bonds
Planned Giving
Medical Community
Research & Resources
PFF Research Funds
I.M. Rosenzweig Junior Investigator Award
Albert Rose Established Investigator Award
Partnership Grants
Sponsorship Opportunities
Leanne Storch Support Group Fund
PFF Summit
PFF Care Center Network
PFF Patient Registry
Statements-HRCT
Statements-HRCT
Connect With Patients
Patient Education Materials
Host an Event
Support Groups
PFF Ambassador Program
CME/CE Library
Health Provider Resources
Home
>
Life with PF
>
Clinical Trials Education Center
>
Pipeline
>
IPF Research
A
A
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Pipeline
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
Local and International
Online Support Communities
Support Group Leader Network
PFF Educational Resources
Webinars
Patient Education Materials
PF Community Resources
Life with Pulmonary Fibrosis
Advocacy in Action Webinar Series
PFF Educational Videos
IPF Research
See below for the latest in research news related to Idiopathic Pulmonary Fibrosis (IPF). This is where the PFF will share relevant news articles, press releases, and study results in the field of IPF.
Indalo Therapeutics presents Phase 1 Clinical Trial results for lead antifibrotic drug candidate IDL-2965
by Kelsey Overberg
Dec 4, 2019
Full story
: Indalo Therapeutics presents Phase 1 Clinical Trial results for lead antifibrotic drug candidate IDL-2965
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
by Kelsey Overberg
Dec 4, 2019
Full story
: Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Yale study provides insights into how fibrosis progresses in the human lung
by Kelsey Overberg
Dec 4, 2019
Full story
: Yale study provides insights into how fibrosis progresses in the human lung
Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-analysis
by Kelsey Overberg
Dec 4, 2019
Full story
: Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-analysis
Veracyte Announces New Data Demonstrating ENVISIA Genomic Classifer Improves IPF Diagnosis
by Kelsey Overberg
Dec 4, 2019
Full story
: Veracyte Announces New Data Demonstrating ENVISIA Genomic Classifer Improves IPF Diagnosis
Veracyte announces data published in the Lancet Respiratory Medicine demonstrate that the Envisia Genomic Classifier improves diagnosis of IPF
by Kelsey Overberg
Dec 4, 2019
Full story
: Veracyte announces data published in the Lancet Respiratory Medicine demonstrate that the Envisia Genomic Classifier improves diagnosis of IPF
US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
by Kelsey Overberg
Dec 4, 2019
Full story
: US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
Promising steps towards a treatment for pulmonary fibrosis
by Kelsey Overberg
Dec 4, 2019
Full story
: Promising steps towards a treatment for pulmonary fibrosis
miRagen Presents Preclinical Data in Pulmonary Fibrosis Using Second Generation microRNA-29 Replacement Product Candidate at the 2019 American Thoracic Society International Conference
by Kelsey Overberg
Dec 4, 2019
Full story
: miRagen Presents Preclinical Data in Pulmonary Fibrosis Using Second Generation microRNA-29 Replacement Product Candidate at the 2019 American Thoracic Society International Conference
Mortality for sarcoidosis patients on the transplant wait list in the Lung Allocation Score era: Experience from a high volume center
by Kelsey Overberg
Dec 4, 2019
Full story
: Mortality for sarcoidosis patients on the transplant wait list in the Lung Allocation Score era: Experience from a high volume center
L-CsA-i demonstrates therapeutic potential for Bonchiolitis Obliterans Syndrome (BOS)
by Kelsey Overberg
Dec 4, 2019
Full story
: L-CsA-i demonstrates therapeutic potential for Bonchiolitis Obliterans Syndrome (BOS)
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
by Kelsey Overberg
Dec 4, 2019
Full story
: Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Galecto raises €79 million ($90 million) to run late-phase IPF trial
by Kelsey Overberg
Dec 4, 2019
Full story
: Galecto raises €79 million ($90 million) to run late-phase IPF trial
Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409)
by Kelsey Overberg
Dec 4, 2019
Full story
: Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409)
Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis Given Nintedanib
by Kelsey Overberg
Dec 4, 2019
Full story
: Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis Given Nintedanib
Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
by Kelsey Overberg
Dec 4, 2019
Full story
: Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
by Kelsey Overberg
Dec 4, 2019
Full story
: Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
Analysis of fibroblast migration dynamics in idiopathic pulmonary fibrosis using image-based scaffolds of the lung extracellular matrix
by Marisa Tisler, Samuel Alkmin, Hsin-Yu Chang, Jon Leet, Ksenija Bernau, Nathan Sandbo, and Paul J. Campagnola
Dec 4, 2019
Full story
: Analysis of fibroblast migration dynamics in idiopathic pulmonary fibrosis using image-based scaffolds of the lung extracellular matrix
Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019
by Kelsey Overberg
Dec 3, 2019
Full story
: Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019
Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche
by Kelsey Overberg
Nov 20, 2019
Full story
: Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche
1
(current)
2
3